What is AMKR's health score?

AMKOR TECHNOLOGY, INC. (AMKR) has a TradeApes health score of 50 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is AMKR's estimated fair value?

Based on our 5-year discounted cash flow model, AMKOR TECHNOLOGY, INC.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is AMKR undervalued or overvalued?

Our model currently rates AMKR as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for AMKR... Refresh in a moment for the full analysis.

AMKOR TECHNOLOGY, INC. (AMKR)

Technology Overvalued low mixed

$64.95

Updated: 2026-06-06

TradeApes Score

Financial Strength

80 Strong

Operating Trend

48 Mixed

Relative Value

15 Stressed

Capital Allocation

45 Mixed

Risk

70 Healthy

Key Findings

+ Low leverage — net debt/EBITDA below 1×

Unlock Full Report →

− Historically expensive — EV/EBITDA in top 20% of its 5-year range

Unlock Full Report →

2 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.